| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4307069 | Surgery | 2013 | 7 Pages |
Abstract
We have developed a novel molecule which demonstrates functional inhibition of CaSR and has a favorable structure for labeling. This compound appears to be appropriate for further development as a molecular imaging tool to enhance the surgical treatment of parathyroid disease and MTC.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Adlina Mohd PhD, Shankaran PhD, Xiaoli PhD, Motoyasu MD, PhD, Matthew D. MD, Michael F. PhD, John E. MD,